PeterGottliebMD
Endocrinology • Aurora, CODiabetes, Lipid Metabolism
Professor, Pediatrics, University of Colorado School of Medicine
Dr. Gottlieb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 303-493-7000Fax+1 303-724-6779
Summary
- Dr. Peter Gottlieb is an endocrinologist in Aurora, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital and Children's Hospital Colorado. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 33 years. He specializes in diabetes and lipid metabolism and is experienced in diabetes mellitus, chronic adrenal insufficiency, and autoimmune disease.
Education & Training
UMass Chan Medical SchoolFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990- UMass Chan Medical SchoolResidency, Internal Medicine, 1984 - 1987
Rutgers Robert Wood Johnson Medical SchoolClass of 1984
Certifications & Licensure
CO State Medical License 1994 - 2025
MA State Medical License 1986 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus Start of enrollment: 2006 Oct 01
- A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01
- The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes.Catherine A Nicholas, Fatima A Tensun, Spencer A Evans, Kevin P Toole, Jessica E Prendergast
Cell Reports. 2025-03-19 - 2 citationsGenetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives.Taylor M Triolo, Hemang M Parikh, Mustafa Tosur, Lauric A Ferrat, Lu You
The Journal of Clinical Endocrinology and Metabolism. 2025-03-17 - Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects.Anita C Hohenstein, Joylynn Gallegos, Mylinh Dang, Jason Groegler, Hali Broncucia
Diabetes. 2025-01-16
Journal Articles
- Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 DiabetesPeter Gottlieb, MD, Diabetes Care
- Learning from Past Failures of Oral Insulin TrialsPeter A Gottlieb, Aaron W Michels, Diabetes Care
Press Mentions
New Therapy First to Target Type 1 Diabetes Disease ProcessApril 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
